CRYSTALLINE FORM OF 1´-(1-METHYLETHYL)- 4´-[(2-FLUORO-4-METHOXYPHENYL)METHYL]-5´-METHYL-1H-PYRAZOL-3´-O-ß-D-GLUCOPYRANOSIDE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS

The invention relates to a crystalline form of 1´-(1-methylethyl)- 4´-[(2-fluoro-4- methoxyphenyl)methyl]-5´-methyl-1H-pyrazol-3´-O-ß-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments. La présente invention concerne une forme cristall...

Full description

Saved in:
Bibliographic Details
Main Authors MAIER, STEFFEN, RITTER, REGINE, EICKELMANN, PETER, PINNETTI, SABINE, DUGI, KLAUS, SCHILCHER, GEBHARD, THOMAS, LEO, ADELGOSS, GEBHARD, DURAN, ADIL, KRAEMER, GERD, MARTIN, HANS-JUERGEN, STREICHER, RUEDIGER
Format Patent
LanguageEnglish
French
Published 19.07.2007
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a crystalline form of 1´-(1-methylethyl)- 4´-[(2-fluoro-4- methoxyphenyl)methyl]-5´-methyl-1H-pyrazol-3´-O-ß-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments. La présente invention concerne une forme cristalline de 1´-(1-méthyléthyl)- 4´-[(2-fluoro-4-méthoxyphényl)méthyl]-5´-méthyl-1h-pyrazol-3´-o-ß-d-glucopyranoside, un procédé permettant sa préparation ainsi que l'utilisation du composé précité pour la préparation de médicaments.
Bibliography:Application Number: WO2007EP50209